A recent article in The Conversation U.S. highlights cutting-edge research from the Mangalam Lab in the Department of Pathology at the University of Iowa, based on their newly published study in PNAS. The study uncovers a key link between gut microbiota and multiple sclerosis (MS), identifying a specific bacterial ratio that may act as a biomarker for the disease and help predict its severity.

Featuring: Anthony Avellino, BS, MS; Xiaochun Han; Jiaqing Hao, PhD; Sarah Hornberg, BS, MLS (ASCP); Xingshan Jiang, PhD; Anna Merrill, PhD, DABCC; Bing Li, PhD; Shanshan Liu, PhD; Anthony N. Snow, MD; Yiqin Xiong, MD, PhD; Zhaohua Wang, PhD; Jianyu Yu, MS

Featuring: Dustin Bosch, MD, PhD; Mohamed Eletrebi, MBBCh; Amr Masaadeh, MBBS; Douglas Spitz, PhD

Featuring: Kathryn Eschbacher, MD; Stefan Strack, PhD

Featuring: Alexander Boyden, PhD; Stephanie J. Chen, MD; Sudeep Ghimire, PhD; Nitin Karandikar, MD, PhD; Kevin Legge, PhD; Peter Lehman, MS, Vincent Liu, MD, FAAD; Ashutosh Mangalam, PhD; David K. Meyerholz, DVM, PhD; Jane Persons, MD, PhD; Kai Rogers, MD, PhD; Shailesh, K. Shahi, PhD; Munir Tanas, MD; Mohit Upadhye, MD; Chakrapani Vemulawada, PhD; Connor Wilhelm, MS